Page last updated: 2024-10-29

isoproterenol and Long QT Syndrome 1

isoproterenol has been researched along with Long QT Syndrome 1 in 2 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Research Excerpts

ExcerptRelevanceReference
" Here, we present a case of cryptogenic underlying congenital long QT syndrome (cLQTS) successfully treated with isoproterenol, a drug contraindicated in most congenital forms of this condition."3.88Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man. ( Bunin, J; Guess, J; Hubel, K; Madigan, CG; Wiggins, A, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guess, J1
Hubel, K1
Wiggins, A1
Madigan, CG1
Bunin, J1
Moretti, A1
Bellin, M1
Welling, A1
Jung, CB1
Lam, JT1
Bott-Flügel, L1
Dorn, T1
Goedel, A1
Höhnke, C1
Hofmann, F1
Seyfarth, M1
Sinnecker, D1
Schömig, A1
Laugwitz, KL1

Other Studies

2 other studies available for isoproterenol and Long QT Syndrome 1

ArticleYear
Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man.
    The American journal of case reports, 2018, Dec-20, Volume: 19

    Topics: Cardiotonic Agents; Electrocardiography; Humans; Isoproterenol; KCNQ1 Potassium Channel; Long QT Syn

2018
Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
    The New England journal of medicine, 2010, Oct-07, Volume: 363, Issue:15

    Topics: Action Potentials; Adrenergic beta-Antagonists; Adult; Aged; Cardiotonic Agents; Child; Female; Fibr

2010